Young Boy Dies of Cardiac Arrest in Pfizer Gene Therapy Trial

This article originally appeared on The Gateway Pundit and was republished with permission.

Guest post by Anthony Scott

Pharmaceutical giant Pfizer has reported a young boy died due to cardiac arrest after receiving the company’s experimental gene therapy for Duchenne muscular dystrophy.

A Pfizer spokesperson told Reuters in an exclusive email, “A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study.”

Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.

According to Johns Hopkins Medicine, Duchenne muscular dystrophy (DMD) “is caused by a genetic problem in producing dystrophin, a protein that protects muscle fibers from breaking down when exposed to enzymes.”

“A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last… pic.twitter.com/hLLAk1kAdn

— Chief Nerd (@TheChiefNerd) May 8, 2024

Per Reuters:

A young patient died due to cardiac arrest after receiving Pfizer’s gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular dystrophy(DMD), the drugmaker told Reuters on Tuesday.

“A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study,” a company spokesperson told Reuters in an emailed response.

The trial is testing boys 2 to three years of age with DMD, a genetic muscle wasting disorder in which most patients lack the protein dystrophin which keeps muscles intact. The disorder affects an estimated one-in-3,500 male births worldwide.

“The patient received the investigational gene therapy, fordadistrogene movaparvovec, in early 2023,” as per a statement from a community letter attributed to the drugmaker’s DMD gene therapy team and posted by a nonprofit advocacy group.

READ:

We are absolutely devastated to hear about the sudden passing of a young boy (2-3 years old) who was participating in Pfizer’s Phase 2 Daylight study! 👼🌹💔😢👼💔⬇️

We are praying for peace and comfort for his family and friends. Fly high sweet Duchenne Warrior. pic.twitter.com/blZhLpqCoj

— “Sudden And Unexpected” (@toobaffled) May 7, 2024

Pfizer announced they are currently reviewing the patient’s data to understand what caused the boy to suffer an adverse event.

Young boy dies in trial for Pfizer Duchenne gene therapy – STAT. But it couldn’t be the vaccine! https://t.co/WRf3PLdGAk

— Steve Kirsch (@stkirsch) May 8, 2024

Nuremberg 2 is coming and they will pay! https://t.co/UqjgiK8jJO

— Alex Jones (@RealAlexJones) May 8, 2024

Copyright 2024 The Gateway Pundit